Assure (IONM)
(Delayed Data from NSDQ)
$0.51 USD
-0.02 (-4.28%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.50 -0.01 (-1.07%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.51 USD
-0.02 (-4.28%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.50 -0.01 (-1.07%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Inotiv, Inc. (NOTV) Q3 Earnings Miss Estimates
by Zacks Equity Research
Inotiv, Inc. (NOTV) delivered earnings and revenue surprises of -73.08% and 6.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
The Beauty Health Company (SKIN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
The Beauty Health Company (SKIN) delivered earnings and revenue surprises of 40% and 0.91%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
ModivCare (MODV) Misses Q2 Earnings Estimates
by Zacks Equity Research
ModivCare (MODV) delivered earnings and revenue surprises of -2.65% and 7.90%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
NovoCure (NVCR) delivered earnings and revenue surprises of -8% and 2.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Sharecare, Inc. (SHCR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sharecare, Inc. (SHCR) delivered earnings and revenue surprises of 25% and 4.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Ascend Wellness Holdings, Inc. (AAWH) delivered earnings and revenue surprises of -100% and 4.65%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
LumiraDx Limited (LMDX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
LumiraDx Limited (LMDX) delivered earnings and revenue surprises of -68.42% and 7.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
The Beauty Health Company (SKIN) Q4 Earnings Meet Estimates
by Zacks Equity Research
The Beauty Health Company (SKIN) delivered earnings and revenue surprises of 0% and 3.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareDx (CDNA) delivered earnings and revenue surprises of -16.67% and 0.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Assure Holdings Corp. (IONM) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -28.57% and 17.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
CoDiagnostics, Inc. (CODX) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 33.33% and 24.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Brookdale Senior Living (BKD) Reports Q3 Loss
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -15.38% and 0%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Assure Holdings Corp. (IONM) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -60.87% and 72.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
OYSTER PT PHARM (OYST) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
OYSTER PT PHARM (OYST) delivered earnings and revenue surprises of -14.02% and 2.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
LifeStance Health Group (LFST) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
LifeStance Health (LFST) delivered earnings and revenue surprises of -58.33% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Progyny (PGNY) delivered earnings and revenue surprises of 350% and 2.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Assure Holdings Corp. (IONM) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -216.67% and 27.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Armata Pharmaceuticals, Inc. (ARMP) delivered earnings and revenue surprises of -50% and 30.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
OncoCyte (OCX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
OncoCyte (OCX) delivered earnings and revenue surprises of 15.38% and 16.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Agiliti (AGTI) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of 26.09% and 0.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Progyny (PGNY) delivered earnings and revenue surprises of 150% and 2.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Premier, Inc. (PINC) Matches Q3 Earnings Estimates
by Zacks Equity Research
Premier, Inc. (PINC) delivered earnings and revenue surprises of 0% and 2.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Tivity Health (TVTY) Moves 5.2% Higher: Will This Strength Last?
by Zacks Equity Research
Tivity Health (TVTY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Assure Holdings Corp. (IONM) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -50% and 8.53%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Assure Holdings Corp. (IONM): Can Its 7.3% Jump Turn into More Strength?
by Zacks Equity Research
Assure Holdings Corp. (IONM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.